📰 Nuclear Export News
Page 16 - Nuclear Export News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nuclear Export. Real-time updates on events, politics, business and more.
March 30, 2022
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
March 30, 2022
Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
March 29, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...
March 29, 2022
Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) have been assigned a consensus recommendation of “Hold” from the eight research firms that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month target price […]
March 21, 2022
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its price objective trimmed by HC Wainwright from $23.00 to $22.00 in a research report report published on Friday morning, MarketBeat reports. The firm currently has a buy rating on the stock. Several other equities analysts have also weighed in on the stock. SVB Leerink cut their price […]
March 17, 2022
NEWTON, Mass. - Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that results from the Phase 3 SIENDO study will be presented at... | March 17, 2022
March 16, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
March 16, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
March 15, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
March 14, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...